UBS AM’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $795M | Sell |
7,684,996
-613,102
| -7% | -$54.7M | 0.14% | 117 |
|
|
2026
Q1 | $596M | Sell |
8,298,098
-14,243
| -0.2% | -$1.1M | 0.12% | 148 |
|
|
2025
Q4 | $660M | Buy |
8,312,341
+387,467
| +5% | +$30.5M | 0.14% | 126 |
|
|
2025
Q3 | $597M | Sell |
7,924,874
-1,452,125
| -15% | -$99.5M | 0.13% | 132 |
|
|
2025
Q2 | $647M | Buy |
9,376,999
+1,054,177
| +13% | +$69.1M | 0.13% | 147 |
|
|
2025
Q1 | $564M | Sell |
8,322,822
-100,786
| -1% | -$6.03M | 0.14% | 144 |
|
|
2024
Q4 | $378M | Buy |
8,423,608
+1,373,663
| +19% | +$77.1M | 0.09% | 207 |
|
|
2024
Q3 | $443M | Buy |
7,049,945
+107,977
| +2% | +$6.3M | 0.11% | 163 |
|
|
2024
Q2 | $410M | Buy |
6,941,968
+1,306,009
| +23% | +$81.7M | 0.12% | 148 |
|
|
2024
Q1 | $450M | Sell |
5,635,959
-660,191
| -10% | -$50.4M | 0.16% | 121 |
|
|
2023
Q4 | $497M | Sell |
6,296,150
-25,360
| -0.4% | -$1.8M | 0.2% | 99 |
|
|
2023
Q3 | $441M | Sell |
6,321,510
-314,000
| -5% | -$22.2M | 0.2% | 98 |
|
|
2023
Q2 | $493M | Hold |
6,635,510
| – | – | 0.24% | 85 |
|
|
2023
Q1 | $493M | Buy |
6,635,510
+1,209,579
| +22% | +$101M | 0.24% | 85 |
|
|
2022
Q4 | $506M | Buy |
5,425,931
+268,082
| +5% | +$25.9M | 0.27% | 81 |
|
|
2022
Q3 | $492M | Sell |
5,157,849
-493,240
| -9% | -$48.8M | 0.28% | 72 |
|
|
2022
Q2 | $524M | Buy |
5,651,089
+431,731
| +8% | +$42.1M | 0.27% | 72 |
|
|
2022
Q1 | $528M | Sell |
5,219,358
-451,506
| -8% | -$47.4M | 0.23% | 86 |
|
|
2021
Q4 | $585M | Buy |
5,670,864
+484,834
| +9% | +$44.8M | 0.22% | 96 |
|
|
2021
Q3 | $440M | Sell |
5,186,030
-81,410
| -2% | -$6.82M | 0.18% | 119 |
|
|
2021
Q2 | $440M | Sell |
5,267,440
-164,864
| -3% | -$13.5M | 0.19% | 115 |
|
|
2021
Q1 | $409M | Buy |
5,432,304
+108,612
| +2% | +$7.91M | 0.18% | 115 |
|
|
2020
Q4 | $364M | Buy |
5,323,692
+348,206
| +7% | +$22.6M | 0.17% | 114 |
|
|
2020
Q3 | $291M | Buy |
4,975,486
+273,547
| +6% | +$17M | 0.16% | 124 |
|
|
2020
Q2 | $305M | Sell |
4,701,939
-75,764
| -2% | -$4.77M | 0.19% | 111 |
|
|
2020
Q1 | $283M | Buy |
4,777,703
+373,344
| +8% | +$24.9M | 0.2% | 94 |
|
|
2019
Q4 | $327M | Buy |
4,404,359
+130,785
| +3% | +$9.18M | 0.2% | 95 |
|
|
2019
Q3 | $270M | Sell |
4,273,574
-66,054
| -2% | -$3.91M | 0.18% | 113 |
|
|
2019
Q2 | $236M | Sell |
4,339,628
-1,073,447
| -20% | -$57.8M | 0.17% | 119 |
|
|
2019
Q1 | $292M | Sell |
5,413,075
-138,995
| -3% | -$8.58M | 0.22% | 89 |
|
|
2018
Q4 | $364M | Buy |
5,552,070
+1,785,953
| +47% | +$133M | 0.31% | 62 |
|
|
2018
Q3 | $296M | Sell |
3,766,117
-69,186
| -2% | -$4.95M | 0.22% | 92 |
|
|
2018
Q2 | $247M | Sell |
3,835,303
-67,829
| -2% | -$4.47M | 0.19% | 106 |
|
|
2018
Q1 | $243M | Buy |
3,903,132
+318,483
| +9% | +$22.9M | 0.19% | 109 |
|
|
2017
Q4 | $260M | Buy |
3,584,649
+194,553
| +6% | +$14.1M | 0.22% | 98 |
|
|
2017
Q3 | $276M | Buy |
3,390,096
+61,839
| +2% | +$4.89M | 0.25% | 85 |
|
|
2017
Q2 | $268M | Buy |
3,328,257
+159,577
| +5% | +$12.6M | 0.26% | 82 |
|
|
2017
Q1 | $249M | Sell |
3,168,680
-141,619
| -4% | -$11.3M | 0.25% | 85 |
|
|
2016
Q4 | $261M | Sell |
3,310,299
-2,114,773
| -39% | -$171M | 0.29% | 72 |
|
|
2016
Q3 | $483M | Buy |
5,425,072
+569,065
| +12% | +$53.7M | 0.52% | 37 |
|
|
2016
Q2 | $465M | Buy |
4,856,007
+91,148
| +2% | +$9.08M | 0.53% | 36 |
|
|
2016
Q1 | $494M | Buy |
4,764,859
+531,568
| +13% | +$51.7M | 0.57% | 32 |
|
|
2015
Q4 | $414M | Sell |
4,233,291
-277,847
| -6% | -$27.2M | 0.47% | 40 |
|
|
2015
Q3 | $435M | Sell |
4,511,138
-361,511
| -7% | -$38M | 0.48% | 40 |
|
|
2015
Q2 | $511M | Buy |
4,872,649
+431,448
| +10% | +$44.1M | 0.49% | 39 |
|
|
2015
Q1 | $458M | Buy |
4,441,201
+75,351
| +2% | +$7.62M | 0.44% | 47 |
|
|
2014
Q4 | $420M | Buy |
4,365,850
+58,759
| +1% | +$5.18M | 0.4% | 51 |
|
|
2014
Q3 | $343M | Buy |
4,307,091
+52,046
| +1% | +$4.1M | 0.34% | 68 |
|
|
2014
Q2 | $321M | Buy |
4,255,045
+203,205
| +5% | +$15.4M | 0.32% | 68 |
|
|
2014
Q1 | $303M | Buy |
4,051,840
+124,496
| +3% | +$8.79M | 0.32% | 68 |
|
|
2013
Q4 | $281M | Buy |
3,927,344
+22,466
| +0.6% | +$1.44M | 0.32% | 69 |
|
|
2013
Q3 | $222M | Sell |
3,904,878
-15,624
| -0.4% | -$931K | 0.27% | 94 |
|
|
2013
Q2 | $224M | Buy |
+3,920,502
| New | +$227M | 0.29% | 86 |
|
Other funds holding CVS
UBS AM's CVS Position: Q2 2026 in Review
UBS AM reduced its CVS Health (CVS) stake by 7.4% in Q2 2026, selling an estimated $54.7M and leaving 7,684,996 shares worth $795M. The position accounts for 0.14% of the portfolio, ranked #117.
UBS AM first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- UBS AM held 7,684,996 shares of CVS Health worth $795M as of Q2 2026.
- UBS AM sold 613,102 CVS Health shares in Q2 2026, an estimated $54.7M.
- CVS Health made up 0.14% of UBS AM's portfolio in Q2 2026, its #117 holding.
- UBS AM first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.